Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Daumke, Oliver Prof. Dr. (1) Franke, Vedran Dr. (1) Hübner, Norbert Prof. Dr. (1) Kolesnichenko, Marina Dr. (1) Patone, Giannino Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (1) (-) Janz, Martin Dr. (6) (-) Mathas, Stephan Dr. (7) 1999 (2) 2000 (2) 2001 (1) 2002 (6) 2003 (3) 2004 (3) 2005 (3) 2006 (5) 2007 (4) 2008 (4) 2009 (4) 2010 (3) (-) 2011 (4) (-) 2012 (2) 2013 (3) 2014 (2) 2015 (5) 2016 (3) 2017 (5) 2018 (1) (-) 2019 (2) 2020 (6) 2021 (3) 2022 (7) 2023 (10) 2024 (2) Bioinformatics and Omics Data Science (1) (-) Biology of Malignant Lymphomas (8) Genetics and Genomics of Cardiovascular Diseases (1) Immune Regulation and Cancer (1) Proteome Dynamics (1) Structural Biology of Membrane-Associated Processes (1) 8 Results: Active Filter: Janz, Martin Dr.Mathas, Stephan Dr.Biology of Malignant Lymphomas201120122019 Sort: Result score Newest to oldest Oldest to newest April 14, 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas July 14, 2011 / Oncogene Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells U.M. Fagerli K. Ullrich T. Stuehmer T. Holien K. Koechert R.U. Holt O. Bruland M. Chatterjee H. Nogai G. Lenz J.D. Shaughnessy S. Mathas A. Sundan R.C. Bargou B. Doerken M. Borset M. Janz November 01, 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas June 01, 2019 / Leukemia Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma B. Edginton-White P. Cauchy S.A. Assi S. Hartmann A.G. Riggs S. Mathas P.N. Cockerill C. Bonifer August 01, 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas November 01, 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky August 01, 2011 / J Exp Med Genomic loss of the putative tumor suppressor gene E2A in human lymphoma A. Steininger M. Moebs R. Ullmann K. Koechert S. Kreher B. Lamprecht I. Anagnostopoulos M. Hummel J. Richter M. Beyer M. Janz C.D. Klemke H. Stein B. Doerken W. Sterry E. Schrock S. Mathas C. Assaf March 28, 2019 / Blood Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma L. von Hoff E. Kärgel V. Franke E. McShane K.W. Schulz-Beiss G. Patone N. Schleussner M. Kolesnichenko N. Hübner O. Daumke M. Selbach A. Akalin S. Mathas C. Scheidereit
April 14, 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas
July 14, 2011 / Oncogene Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells U.M. Fagerli K. Ullrich T. Stuehmer T. Holien K. Koechert R.U. Holt O. Bruland M. Chatterjee H. Nogai G. Lenz J.D. Shaughnessy S. Mathas A. Sundan R.C. Bargou B. Doerken M. Borset M. Janz
November 01, 2011 / Br J Haematol BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines K. Ullrich K.D. Wurster B. Lamprecht K. Koechert A. Engert B. Doerken M. Janz S. Mathas
June 01, 2019 / Leukemia Global long terminal repeat activation participates in establishing the unique gene expression programme of classical Hodgkin lymphoma B. Edginton-White P. Cauchy S.A. Assi S. Hartmann A.G. Riggs S. Mathas P.N. Cockerill C. Bonifer
August 01, 2012 / Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas
November 01, 2012 / Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky
August 01, 2011 / J Exp Med Genomic loss of the putative tumor suppressor gene E2A in human lymphoma A. Steininger M. Moebs R. Ullmann K. Koechert S. Kreher B. Lamprecht I. Anagnostopoulos M. Hummel J. Richter M. Beyer M. Janz C.D. Klemke H. Stein B. Doerken W. Sterry E. Schrock S. Mathas C. Assaf
March 28, 2019 / Blood Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma L. von Hoff E. Kärgel V. Franke E. McShane K.W. Schulz-Beiss G. Patone N. Schleussner M. Kolesnichenko N. Hübner O. Daumke M. Selbach A. Akalin S. Mathas C. Scheidereit